Abbott Ups Vascular, Ophthalmic Focus With Two Acquisitions

Abbott Laboratories announced July 15 it has entered into agreements to purchase stent manufacturer IDev Technologies and ophthalmic device company OptiMedica Corp. The acquisitions are intended to bolster the company’s medical device unit in the vascular and vision care businesses, respectively.

More from Strategy

More from Business